{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:13:05Z","timestamp":1761959585017,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":137,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.lrr.2022.100327","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T23:38:59Z","timestamp":1653003539000},"page":"100327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A rare case of B-lymphoid blast phase of chronic myeloid leukemia: Diagnostic challenges"],"prefix":"10.1016","volume":"17","author":[{"given":"Nada","family":"Naiyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Leslie","family":"Zaslav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahmeena","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yupo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxanna","family":"Ponce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Htien","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lrr.2022.100327_bib0001","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5581\/1516-8484.20110034","article-title":"Dasatinib - clinical trials and management of adverse events in imatinib resistant\/intolerant chronic myeloid leukemia","volume":"33","author":"Conchon","year":"2011","journal-title":"Rev Bras Hematol Hemoter"},{"key":"10.1016\/j.lrr.2022.100327_bib0002","article-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017","journal-title":"IARC PressLyon: [Section: Chronic myeloid leukemia, BCR-ABL1-postive]"},{"issue":"4","key":"10.1016\/j.lrr.2022.100327_bib0003","doi-asserted-by":"crossref","DOI":"10.3109\/10428190109099316","article-title":"Philadelphia-positive B-cell acute lymphoblastic leukemia is initiated in an uncommitted progenitor cell","volume":"42","author":"P\u00e9rez-Losada","year":"2001","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.lrr.2022.100327_bib0004","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V95.3.1007.003k35_1007_1013","article-title":"A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia","volume":"95","author":"Cobaleda","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lrr.2022.100327_bib0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12032-012-0443-1","article-title":"Prognostic importance of additional cytogenetic anomalies in chronic myeloid leukemia","volume":"30","author":"Bozkurt","year":"2013","journal-title":"Med Oncol"},{"issue":"1","key":"10.1016\/j.lrr.2022.100327_bib0006","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cancergencyto.2004.06.011","article-title":"Additional clonal abnormalities in Philadelphia-positive ALL and CML demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progression","volume":"157","author":"Bacher","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"issue":"3","key":"10.1016\/j.lrr.2022.100327_bib0007","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.beha.2016.10.005","article-title":"Management of CML-blast crisis","volume":"29","author":"Hehlmann","year":"2016","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.lrr.2022.100327_bib0008","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cancergen.2020.03.001","article-title":"Evidence-based review of genomic aberrations in B-lymphoblastic leukemia\/lymphoma: Report from the cancer genomics consortium working group for lymphoblastic leukemia","volume":"243","author":"Akkari","year":"2020","journal-title":"Cancer Genet"},{"issue":"12","key":"10.1016\/j.lrr.2022.100327_bib0009","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1080\/10428194.2020.1795160","article-title":"Chronic myeloid leukemia presenting in lymphoblastic crisis, a differential diagnosis with Philadelphia-positive B-lymphoblastic leukemia","volume":"61","author":"Chen","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1016\/j.lrr.2022.100327_bib0010","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.6004\/jnccn.2020.0047","article-title":"Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Deininger","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.lrr.2022.100327_bib0011","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.15_suppl.7001","article-title":"Combination of ponatinib and blinatumomab in Philadelphia chromosome-positive acute lymphoblastic leukemia: Early results from a phase II study","author":"Short","year":"2021","journal-title":"Journal of Clinical Oncology"}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048922000395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048922000395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:08:39Z","timestamp":1761959319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048922000395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":11,"alternative-id":["S2213048922000395"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2022.100327","relation":{},"ISSN":["2213-0489"],"issn-type":[{"type":"print","value":"2213-0489"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A rare case of B-lymphoid blast phase of chronic myeloid leukemia: Diagnostic challenges","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2022.100327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100327"}}